South Korea said it will waive quarantine for foreigners who have been vaccinated against COVID-19 to enter in some cases, such as visiting family, doing business, etc. study or public service.
People who have been fully vaccinated against COVID-19 will not need to be isolated when coming to Korea from July 2021 - Photo: REUTERS
Yonhap news agency quoted South Korean health authorities on June 13 as saying the measure This will apply from 1-7.
Even though they are exempt from quarantine, those who have been vaccinated must still be tested before and after entering Korea.
This policy does not apply to countries that have detected a variant of the new strain of corona virus that causes COVID-19, such as Brazil or South Africa.
Previously, from May 5, South Korea has allowed isolation for those who have been vaccinated in the country.
The Korean Ministry of Culture, Sports and Tourism recently said that the country is seeking agreements with Thailand, Singapore, Taiwan territory, Guam and Saipan territories, in allowing vaccinated people to travel. travel as early as July 2021.
Under the agreement, the travel bubble will establish a limited travel corridor from South Korea's Incheon Airport to a destination in a second country.
Travelers traveling in this travel bubble will not need to be quarantined, but must certified as vaccinated against COVID-19. They also need to have a negative test result before departure and retest on arrival.
The number of new COVID-19 cases in South Korea on June 13 fell below 500 cases / day with the total number of cases currently at about 178,000 cases. The number of new cases per day in the country has remained between 400 and 700 for the past few months.
South Korean health authorities said social distancing rules will continue until July 4. However, the government is expected to relax the curfew for businesses, allowing restaurants and entertainment facilities to operate until midnight instead of 10pm as now.
South Korea has implemented a vaccination program against COVID-19 since the end of February 2021. To date, the first dose has been administered to 11.8 million people, equivalent to 23% of the population.
